NATO News
Las Vegas Convention Center, Las Vegas, Nevada: February 11-13, 2019
TPE 2019 Show: The Tobacco Media Group (TMG) is announcing that the Tobacco Plus Expo 2019 will have a new three-day format and will be held on February 11-13, 2019, in Las Vegas, Nevada. This tobacco show brings together top brands and buyers from the premium tobacco, tobacco-related, vapor, and alternative industries. TPE 2019 is aimed at starting the New Year off with a lively, enjoyable, and educational approach to business growth and profitability for tobacco retailers, and offers the newly-expanded open show floor times of 1:00 PM to 5 PM on Monday, February 11th, 10:30 AM to 5:00 PM on Tuesday, February 12th, and 10:30 AM to 4 PM on Wednesday, February 13th.
Featuring more distributors, wholesalers, and square footage, the TPE 2019 show floor offers expanded opportunities for exhibiting, purchasing, learning, and networking with industry colleagues and acquaintances. Thousands of products will be offered at exclusive show pricing, and a tactical educational track brings additional value with informative and entertaining seminars and discussion panels led by industry standouts.
NATO Education Seminars: Building upon their partnership with TMG, NATO will be co-locating at the TPE 2019 Show as a powerful resource and guide to successfully navigating the current and ever-changing legislative and regulatory environment that affects all aspects of the industry. The NATO-led conference sessions are a wealth of information and inspiration for exhibitors and attendees alike and will be held on Monday, February 11th beginning at 1:30 PM at a special staging area on the show floor.
The confirmed presenters for the NATO education seminar series include the following:
1:30 PM Don Burke, Management Science Associates: Tobacco Market Trends
2:30 PM Thomas Briant, NATO Executive Director: Legislative and FDA Regulatory Update
3:30 PM Bonnie Herzog, Wells Fargo Securities: Wall Street Update on the Tobacco Industry
4:30 PM Cocktail Reception
“TPE 2019 is going to be a can’t miss event,” says Ben Stimpson, Managing Director of Tobacco Media Group. “With our industry gathered together, it’s such an efficient, profitable way to do business, learn from each other, and have some fun along the way.”
All NATO members are encouraged to attend the upcoming TPE 2019 Show. To register to attend the TPE 2019, please click on the link below:
State tobacco-related legislative bills that have been introduced in the past week are listed below alphabetically by state:
New Jersey: Assembly Bill 4391 imposes a 3.5% tax on the retail sales of liquid nicotine which is intended to replace the $.10 per fluid milliliter tax.
New York: Assembly Bill 11337 prohibits the public display of tobacco advertisements and tobacco paraphernalia within 500 feet of schools.
Today, NATO submitted the accompanying comments to the U.S. Food and Drug Administration in response to the agency’s Advanced Notice of Proposed Rulemaking (ANPRM) regarding the role of flavors in tobacco products. In the ANPRM, the FDA requested comments from the public and the industry about the use of flavors in cigarettes (menthol) and other tobacco products. This ANPRM indicates that the agency is considering restrictions or prohibitions on the use of flavors in tobacco products.
In NATO’s comments, the association focuses on many different issues and concerns raised by this ANPRM which include the following:
1. The importance of consumer choice for flavored products whether that be soft drinks, coffee, alcoholic beverages or tobacco products.
2. The Congressional limitation imposed on the FDA that prohibits the agency from banning an entire class of tobacco products. However, an across the board ban on flavors would for all intents and purposes prohibit the sale of pipe tobacco and many other categories of products including...
Read more...Today, NATO submitted the accompanying comments to the U.S. Food and Drug Administration in response to the agency’s Advanced Notice of Proposed Rulemaking (ANPRM) regarding a potential regulation that would set a maximum level of nicotine in cigarettes and possibly other combustible tobacco products. In the ANPRM, the FDA requested comments from the public and the industry about setting nicotine levels in an attempt to make cigarettes and other tobacco products “minimally addictive or non-addictive.” This ANPRM indicates that the agency is looking at reducing nicotine levels in cigarettes by up to 90% from current nicotine levels.
In NATO’s comments, the association focuses on many different issues and concerns raised by this ANPRM which include the following:
1. The need to allow a market for alternative non-combustible and heat-not-burn products to be regulated and approved before maximum nicotine levels in combustible tobacco products would be required.
2. The need for the FDA to conduct an educational campaign so that adults do not serve as a source of tobacco products for underage youth. In the ANPRM, the FDA specifically notes that most underage individuals obtain tobacco products from non-retail sources and NATO has been recommending to the FDA for several years to conduct a...
Read more...State tobacco-related legislative bills that have been acted on by a state legislative committee or state legislature are listed below alphabetically by state:
Delaware: House Bill 417, which limits the tax on premium cigars to no more than 50 cents per cigar was reported from the House Revenue & Finance Committee on June 6, 2018 without a recommendation.
New York: Assembly Bill 8688, which prohibits the sale of most flavored e-liquid products containing nicotine, except for tobacco and menthol, was reported from the Assembly Health Committee and referred to the Codes Committee on June 5, 2018. Senate Bill 8609, which requires registration of vendors of electronic cigarettes and liquid nicotine, was amended on third reading on the Senate floor on June 6, 2018. Senate Bill 8610, which prohibits the sale of most flavored e-liquid products containing nicotine, except for tobacco and menthol, was reported from the Senate Health Committee on May 31, 2018.
